Individual Case Safety Report Replication: An Analysis of Case Reporting Transmission Networks
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Toxicology
Link
https://link.springer.com/content/pdf/10.1007/s40264-022-01251-7.pdf
Reference10 articles.
1. Bate A, Evans SJW. Quantitative signal detection using spontaneous ADR reporting. Pharmacoepidemiol Drug Saf. 2009;18:427–36. https://doi.org/10.1002/pds.1742 (Accessed May 5, 2022).
2. Ghosh R, Kempf D, Pufko A, Martinez LFB, Davis CM, Sethi S. Automation opportunities in pharmacovigilance: an industry survey. Pharm Med. 2020;34:7–18. https://doi.org/10.1007/s40290-019-00320-0 (Accessed May 5, 2022).
3. Stergiopoulos S, Fehrle M, Caubel P, Tan L, Jebson L. Adverse drug reaction case safety practices in large biopharmaceutical organizations from 2007 to 2017: an industry survey. Pharm Med. 2019;33:499–510. https://doi.org/10.1007/s40290-019-00307-x (Accessed May 5, 2022).
4. Hauben M, Reich L, DeMicco J, Kim K. “Extreme duplication” in the US FDA adverse events reporting system database. Drug Saf. 2007;30:551–4. https://doi.org/10.2165/00002018-200730060-00009 (Accessed May 5, 2022).
5. Tregunno PM, Fink DB, Fernandez-Fernandez C, Lázaro-Bengoa E, Norén GN. Performance of probabilistic method to detect duplicate individual case safety reports. Drug Saf. 2014;37:249–58. https://doi.org/10.1007/s40264-014-0146-y (Accessed May 5, 2022).
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Misuse, Abuse and Medication Errors’ Adverse Events Associated with Opioids—A Systematic Review;Pharmaceuticals;2024-07-31
2. The evolving role of disproportionality analysis in pharmacovigilance;Expert Opinion on Drug Safety;2024-06-24
3. Navigating duplication in pharmacovigilance databases: a scoping review;BMJ Open;2024-04
4. Harmonization of individual case safety reports transmission requirements among PAHO reference authorities: a review of their current regulation;Therapeutic Advances in Drug Safety;2024-01
5. The futility of adverse drug event reporting systems for monitoring known safety issues: A case study of myocardial infarction with rofecoxib and other drugs;Pharmacoepidemiology and Drug Safety;2023-10-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3